ClinicalTrials.gg
CompletedNCT05416528CLDEQ-8Updated Nov 28, 2023

Chinese Translation and Validation of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8)

An observational study in Contact Lens, Questionnaire and Contact Lens Discomfort, sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. Completed at 1 site in China. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-28.

Sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
134
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This is a cross-cultural adaptation, evaluation and validation study of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8) among soft contact lens wearers in China.

Read the detailed description

The aim of this study is to translate the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8) into Chinese and evaluate its validity, and reliability among soft contact lens wearers in China. One hundred and thirty-four Chinese soft contact lens wearers will be included in the study. Subjects are required to complete the Chinese version of the 8-item Contact Lens Dry Eye Questionnaire (C-CLDEQ-8) on paper before eye examinations. A subgroup of 50 participants will be asked to complete C-CLDEQ-8 twice to evaluate the repeatability.

02

Conditions studied

  • Contact Lens
  • Questionnaire
  • Contact Lens Discomfort

Keywords

  • the 8-item Contact Lens Dry Eye Questionnaire
  • CLDEQ-8
  • Contact Lens Discomfort
  • Questionnaire
  • Chinese translation and validation
03

In context

Lead sponsor

Zhongshan Ophthalmic Center, Sun Yat-sen University is the lead sponsor of 164 studies on the registry; 80 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The subjects are residents of Guangzhou, China.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age between 18-60
  2. Native Chinese citizens with Chinese as first language
  3. Wearing history with spherical disposable SCL (daily disposable, 2 weeks, or monthly disposable) for a least 1 months;
  4. Willing to sign informed consent

Exclusion criteria

Exclusion Criteria:

  1. Any extended wear of SCLs, including wearing toric or multi-focal SCLs
  2. Use SCL for monovision correction
  3. Having clinically significant anterior segment abnormalities (including iritis and infection of the eye, lids, or ocular adnexa)
  4. Having ocular or systemic disease that would preclude SCL wearing
  5. Best corrected visual acuity of less than 0.8 in either eye
  6. History of refractive or other types of corneal surgeries
  7. Having eyelid abnormalities or functional ocular disorders that would induce relevant discomfort.

8) Having congenital or systemic conditions that would limit the capacity to answer the questionnaire

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
134 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The reliability of the C-CLDEQ-8

    Subjects are asked to complete C-CLDEQ-8. Internal consistency (reliability) of the C-CLDEQ-8 is evaluated using the Cronbach's Alpha analysis and the corrected index of homogeneity. For Cronbach´s Alpha results: \< 0.5 is considered unacceptable; 0.5-0.6 poor; 0.6-0.7 questionable; 0.7-0.8 acceptable; 0.8-0.9 good; and \> 0.9 excellent.

    Time frame: before the ocular examination

Secondary outcomes

  1. The repeatability of the C-CLDEQ-8

    a subgroup of 50 participants are asked to complete C-CLDEQ-8 twice. Intraclasss correlation coefficient between the two scores of the first and second questionnaire evaluation is used to evaluate the repeatability. \>0.7 is considered reliable.

    Time frame: before and after the ocular examination on the same day of visit

  2. Cutoff score for C-CLDEQ-8 to predict "Excellent/Very Good" overall of SCLs.

    The Youden-index method is used to determine the cutoff value of the C-CLDEQ-8 score that maximized sensitivity+specificity -1.

    Time frame: before the ocular examination

07

Study locations

1 site
  • Zhongshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, Guangdong 510060, China
08

References and documents

Publications

  • Gao J, Lai Z, Hu Y, Yang X. Translation and validation of the 8-item contact lens dry eye questionnaire (CLDEQ-8) among Chinese soft contact lens wearers. Cont Lens Anterior Eye. 2025 Jun;48(3):102366. doi: 10.1016/j.clae.2024.102366. Epub 2025 Jan 10. PubMed 39799006 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05416528
Responsible party
Xiao Yang (Professor Xiao Yang, M.D, PhD, Zhongshan Ophthalmic Center, Sun Yat-sen University) — Principal investigator
First posted
Jun 13, 2022
Start date
Nov 18, 2022
Primary completion
Nov 18, 2022
Completion
Apr 22, 2023
Last update
Nov 28, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion